John Nabors Promoted VP of Operations and Sales at StarAligners™

John Nabors has been promoted to Vice President of Operations and Sales. He brings more than 38 years of successful leadership experience, strategic business growth, planning and implementation across sales, marketing, and business development to StarAligners.

In his role, John will utilize his extensive knowledge of the orthodontic aligner industry to further the development and growth of the brand.

John Nabors is a known industry veteran and was tasked with taking StarAligners to the next level, building the brand from a concept to launching Star+, now rebranded as StarAlignersPro™, an orthodontic-led aligner care program for orthodontists to affordably treat mild to moderate aligner cases. Previously, John spent 25 years with 3M Unitek in sales and marketing leadership roles, focusing on photobiomodulation, 3D scanning and the clear aligner business growth opportunities.

“We’re doubling down on our commitment to future growth through investments that enhance our operations by hiring talent like John. I am honored to be working with him and to be able to leverage his vast knowledge of the orthodontic and clear aligner industry,” says CEO of StarAligners, Reid Greenberg. “His leadership in the development of StarAlignersPro™ and working with our orthodontists is just a small portion of what he does for the company, and I’m excited to see how we can work together to bring even more brighter smiles to patients.”

John developed StarAlignersPro to address the orthodontist need to affordably treat mild to moderate aligner cases, as well as to provide a solution to the stress and overhead of doing in-house aligners. The StarAlignersPro Aligner Kit includes, 3D Customized Aligners, Teeth Whitening Foam and offers the new StarAlignersPro Essix™ Retainers, for after treatment care. The brand recently launched retainers made from Essix Ace Retainer material, the best clear material to maintain the patient’s smile, custom-made and created from a final 3D scan of the patient’s teeth.

“I am thrilled to be working with a company that shares my vision for our aligner growth industry,” says John. “Having dedicated myself to the orthodontic profession for so many years, it’s clear that aligners continue to provide proven benefits, and StarAligners is bridging a very important gap in the orthodontic practice’s application offering the best solution for mild to moderate aligner cases.”

Under John’s guidance, StarAligners will launch its latest product, Illumina™, an oral therapy system that enhances gum health, increases circulation using photobiomodulation, using LEDs and provides teeth whitening using blue light at the start of 2022. This at-home self-treatment can be used for 10 minutes per day, per arch, for a healthier and brighter smile, using StarAligners Teeth Whitening Foam for an added boost. “Illumina will be a game changer for aligner patients,” says John.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.